GRM2 and Anxiety: Many researchers speculate that mGluR2/3 agonists may attenuate symptoms by reducing excessive glutamate release through presynaptic mechanisms in key areas of the brain associated with fear and anxiety, such as the PFC, amygdala, hippocampus, and thalamus [7], [52], [59], [79], [80].